Genmab A (GMAB) Change in Cash (2018 - 2026)

Genmab A (GMAB) has reported Change in Cash for 8 consecutive years, with -$22.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash rose 74.71% year-over-year to -$22.0 million; the trailing twelve-month figure through Jun 2026 stood at $82.0 million (up 104.04% YoY), and the FY2025 full-year result was $332.0 million, up 137.43% from the prior year.
• Change in Cash rose to -$22.0 million in Q2 2026 per GMAB's latest filing, from -$183.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $2.6 billion in Q1 2023 and bottomed at -$3.5 billion in Q4 2023.
• Historically, Change in Cash has averaged -$398.1 million across 4 years, with a median of -$87.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Change in Cash surged 403.95% in 2025, then sank 179.22% in 2026.
• Over 4 years, Change in Cash stood at -$3.5 billion in 2023, then surged by 74.56% to -$887.0 million in 2024, then soared by 142.16% to $374.0 million in 2025, then slumped by 105.88% to -$22.0 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$22.0 million, -$183.0 million, and $374.0 million for Q2 2026, Q1 2026, and Q3 2025 respectively.